Standout Papers

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With... 2003 2026 2010 2018 2.4k
  1. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer (2003)
    Masahiro Fukuoka, Seiji Yano et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 21 from Science/Nature 195 standout
Sub-graph 1 of 8

Citing Papers

The biology and management of non-small cell lung cancer
2018 StandoutNature
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
112 intermediate papers

Works of Richard Eek being referenced

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout

Author Peers

Author Last Decade Papers Cites
Richard Eek 2037 102 137 1981 646 38 2.6k
Ichiro Takata 2267 71 123 2647 787 50 3.3k
Panos Fidias 1673 105 138 1811 914 58 2.9k
Russell F. DeVore 2708 97 143 2350 1256 27 3.8k
Kathryn H. Brown 1414 119 149 1723 916 29 2.3k
Eckart Laack 1982 57 107 2191 615 61 2.9k
Kun He 1955 47 213 1223 805 53 3.1k
Cristian Massacesi 1612 65 187 1052 970 64 2.3k
Michael S. Rabin 1872 41 141 2210 641 86 3.2k
Marcelo Marotti 2088 53 170 2660 861 29 3.1k
Ariel López-Chávez 2711 28 148 1853 805 41 3.6k

All Works

Loading papers...

Rankless by CCL
2026